Patexia Logo
Patexia Logo
Products
  • IP Intelligence Reports
  • Patexia Concierge
  • Patent Analyzer
  • Trademarks Analyzer
  • Litigation Analyzer
  • All Products
Services
  • Lateral Opportunities
  • Expert Witness
  • Research Studies
  • Strategic Partnership
  • All Services
IP Community
  • IP Community
  • IP Webinars
  • In the News
Company
  • About Us
  • Press Release
  • Careers
  • Contact Us
Login
JoinBook a Meeting
Patexia Logo
Products
  • IP Intelligence Reports
  • Patexia Concierge
  • Patent Analyzer
  • Trademarks Analyzer
  • Litigation Analyzer
Services
  • Lateral Opportunities
  • Expert Witness
  • Research Studies
  • Strategic Partnership
Company
  • About Us
  • Press Release
  • Careers
  • Contact Us
Resources
  • IP Community
  • IP Webinars
  • In the News
  • Help Center
Contact
  • (310) 909-7611
  • 100 Wilshire Blvd. Suite 700
    Santa Monica, CA 90401 USA
  • info@patexia.com
  • Send a message
Follow Us
Terms and Conditions|Privacy Policy
© 2010-2023 Patexia Inc. All Rights Reserved.
Back to All Articles
Browse articles with tag: Arteries
You must be logged in to create a new article
All Articles
Knobbe Martens
Apr 8, 2024
•
ANDA Litigation
Lateral Moves
Titan Medical Merges With Conavi Medical
Written by:Adam G. Copeland Titan Medical Inc. (“Titan”) announced on March 18, 2024, that it is merging with Conavi Medical Inc. (“Conavi”). Titan is... Read More
Elisabeth Manville
Jun 15, 2012
Nanocontainers to treat narrowed arteries
Researchers from the University of Basel in Switzerland have developed a new treatment to combat the leading cause of death... Read More
Elisabeth Manville
May 16, 2012
Novel treatment for artery disease has advantages over conventional treatments
A new treatment for coronary and peripheral artery disease is superior to corresponding conventional treatments. Two IN.PACT drug-eluting balloons, produced... Read More
Ann Conkle
Dec 22, 2011
Clinical trials begin for bioresorbable peripheral artery disease treatment
Today, Abbott announced the start of European clinicals trial to evaluate its new Esprit™ drug eluting bioresorbable vascular scaffold (BVS)... Read More
Alejandro Freixes
Nov 2, 2011
•
Featured
Analysis: Comparing the latest stents from rivals Abbott and Medtronic
On October 31st, the company Medtronic received US Federal Food and Drug Administration approval to treat Narrow Iliac arteries with... Read More